Good laboratory practice (GLP) can only be applied to experimental (i.e. wet lab) procedures.

Which factor is most likely to hinder client learning? 

Below is the financial data for Micron Technologies (ticker: MU). What is their Debt-to-Equity Ratio for 2022 and how do you interpret this value?   FINANCIAL STATEMENT DATE: 10-K from 10/7/2022 CONSOLIDATED BALANCE SHEETS – USD ($) $ in Millions MU Balance Sheet ASSETS September 1, 2022 September 2, 2021 Cash and Cash Equivalents 8,262.00 7,763.00 Short Term Investments 1,069.00 870.00 Accounts Receivable 5,130.00 5,311.00 Inventory 6,663.00 4,487.00 Assets Held for Sale 13.00 974.00 Other Current Assets 644.00 502.00 Total Current Assets 21,781.00 19,907.00 Long-Term Marketable Investments 1,647.00 1,765.00 Property, Plant and Equipment 38,549.00 33,213.00 Operating lease right-of-use assets 678.00 551.00 Intangible assets 421.00 349.00 Deferred tax assets 702.00 782.00 Goodwill 1,228.00 1,228.00 Other Assets, Noncurrent 1,277.00 1,054.00 Total Assets 66,283.00 58,849.00 LIABILITIES Accounts Payable and Accrued Expenses 6,090.00 5,325.00 Current Debt 103.00 155.00 Other Current Liabilities 1,346.00 944.00 Total Current Liabilities 7,539.00 6,424.00 Long-term Debt 6,803.00 6,621.00 Noncurrent operating lease liabilities 610.00 504.00 Noncurrent unearned government incentives 589.00 808.00 Other noncurrent liabilities 835.00 559.00 Total Liabilities 16,376.00 14,916.00 SHAREHOLDERS’ EQUITY Common Stock 123.00 122.00 Additional Paid in Capital 10,197.00 9,453.00 Retained Earnings 47,274.00 39,051.00 Treasury Stock (7,127.00) (4,695.00) Accumulated other comprehensive loss (560.00) 2.00 Total Equity 49,907.00 43,933.00 Total Liabilities plus Total Equity 66,283.00 58,849.00 Shares Outstanding (in millions): 1,087.17

Below is the financial data for Micron Technologies (ticker: MU). What is their Return on Equity (ROE) for 2022? State your answer as a percentage with two decimal places of accuracy, not in decimal form (e.g., 13.21 not .1321).   FINANCIAL STATEMENT DATE: 10-K from 10/7/2022 CONSOLIDATED BALANCE SHEETS – USD ($) $ in Millions MU Balance Sheet ASSETS September 1, 2022 September 2, 2021 Cash and Cash Equivalents 8,262.00 7,763.00 Short Term Investments 1,069.00 870.00 Accounts Receivable 5,130.00 5,311.00 Inventory 6,663.00 4,487.00 Assets Held for Sale 13.00 974.00 Other Current Assets 644.00 502.00 Total Current Assets 21,781.00 19,907.00 Long-Term Marketable Investments 1,647.00 1,765.00 Property, Plant and Equipment 38,549.00 33,213.00 Operating lease right-of-use assets 678.00 551.00 Intangible assets 421.00 349.00 Deferred tax assets 702.00 782.00 Goodwill 1,228.00 1,228.00 Other Assets, Noncurrent 1,277.00 1,054.00 Total Assets 66,283.00 58,849.00 LIABILITIES Accounts Payable and Accrued Expenses 6,090.00 5,325.00 Current Debt 103.00 155.00 Other Current Liabilities 1,346.00 944.00 Total Current Liabilities 7,539.00 6,424.00 Long-term Debt 6,803.00 6,621.00 Noncurrent operating lease liabilities 610.00 504.00 Noncurrent unearned government incentives 589.00 808.00 Other noncurrent liabilities 835.00 559.00 Total Liabilities 16,376.00 14,916.00 SHAREHOLDERS’ EQUITY Common Stock 123.00 122.00 Additional Paid in Capital 10,197.00 9,453.00 Retained Earnings 47,274.00 39,051.00 Treasury Stock (7,127.00) (4,695.00) Accumulated other comprehensive loss (560.00) 2.00 Total Equity 49,907.00 43,933.00 Total Liabilities plus Total Equity 66,283.00 58,849.00 Shares Outstanding (in millions): 1,087.17 FINANCIAL STATEMENT DATE: 10-K from 10/7/2022 CONSOLIDATED STATEMENTS OF EARNINGS – USD ($) in Millions 12 Months Ended Description September 1, 2022 September 2, 2021 Net Sales 30,758 27,705 Cost of Goods Sold 16,860 17,282 Selling, General and Administrative Expense 1,066 894 Research and Development (R&D) 3,116 2,663 Restructuring and Asset Impairments 48 488 Other Operating Income (Expense), Net (34) 95 Operating Income (EBIT) 9,702 6,283 Interest Expense 189 183 Interest Income 96 37 Other Nonoperating Income (Expense) (38) 81 Earnings from Continuing Operations Before Income Taxes 9,571 6,218 Income Taxes 888 394 Net Income Attributable to Common Shareholders 8,683 5,824 Depreciation (from Statement of Cash Flows) 7,116 6,214 Weighted Average Cost of Capital (WACC) 8.76% 9.18% Tax Rate 9.28% 6.34% Stock Price on 09/01/22 $57.19

Which of the following genomic methods is most computationally expensive?

Which of the following is considered a potential drawback to shotgun sequencing approaches to metagenomic studies:

The Wrangler food pantry and garden is open to the entire OC campus community.

Which of the following is/are true about the single-reaction FluA/B surveillance multiplex RT-PCR method:

Which of the following tools require more experienced personnel/expertise and/or higher computational infrastructure

Which of the following terms describes the prokaryotic ribosome binding site (RBS)?